The present status and future potential of radiotherapy in the management of esophageal cancer
- PMID: 402201
- DOI: 10.1002/1097-0142(197702)39:2+<882::aid-cncr2820390726>3.0.co;2-x
The present status and future potential of radiotherapy in the management of esophageal cancer
Abstract
The management of 2032 patients with squamous esophageal cancer seen in Edinburgh from 1931 to 1969 was studied. Since 1949 more radical surgical treatment has been offered and since 1956 more radical radiotherapy. From 1949 to 1969 there has been a swing over from mainly surgical to mainly radiation treatment associated with a rise in the overall one and five-year survival rates to 32% and 9% respectively. The main reason for failure is the prevalence of disseminated disease. The significant mortality of surgical treatment limits its usefulness. Too often, radiotherapy fails because of recurrence of tumor within the irradiated volume. In the upper 2/3 of the esophagus irradiation is preferable to surgery because of better sirvoval. In the lower 1/3 the two methods achieve similar long term survival but following irradiation the short term survival is better and the patient retains a normal stomach. Improvement could be achieved by prevention, earlier diagnosis, improved tumor delineation and a wide range of measures to improve the local effectiveness of irradiation.
Similar articles
-
Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma.Dis Esophagus. 2008;21(6):502-7. doi: 10.1111/j.1442-2050.2007.00797.x. Dis Esophagus. 2008. PMID: 18840135
-
Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.Eur J Cardiothorac Surg. 2009 Jan;35(1):1-7. doi: 10.1016/j.ejcts.2008.09.002. Epub 2008 Oct 15. Eur J Cardiothorac Surg. 2009. PMID: 18926712
-
[Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].Zhonghua Zhong Liu Za Zhi. 2017 Jan 23;39(1):48-55. doi: 10.3760/cma.j.issn.0253-3766.2017.01.010. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28104034 Chinese.
-
[New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].Gan To Kagaku Ryoho. 2000 Nov;27(13):2016-22. Gan To Kagaku Ryoho. 2000. PMID: 11103231 Review. Japanese.
-
Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.Ann Thorac Surg. 2004 Oct;78(4):1177-83. doi: 10.1016/j.athoracsur.2004.02.068. Ann Thorac Surg. 2004. PMID: 15464466 Review.
Cited by
-
Carcinoma of the esophagus: results of treatment.Ann Surg. 1979 Dec;190(6):684-9. doi: 10.1097/00000658-197912000-00002. Ann Surg. 1979. PMID: 92916 Free PMC article.
-
Cancer of the esophagus: the Wayne State University experience.Invest New Drugs. 1989 Apr;7(1):91-100. doi: 10.1007/BF00178195. Invest New Drugs. 1989. PMID: 2661486 Review.
-
The medicinal fungus Antrodia cinnamomea regulates DNA repair and enhances the radiosensitivity of human esophageal cancer cells.Onco Targets Ther. 2016 Oct 27;9:6651-6661. doi: 10.2147/OTT.S96355. eCollection 2016. Onco Targets Ther. 2016. PMID: 27826196 Free PMC article.
-
Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia.Ann Surg. 1983 Oct;198(4):531-40. doi: 10.1097/00000658-198310000-00013. Ann Surg. 1983. PMID: 6194763 Free PMC article.
-
Radiotherapy in management of gastrointestinal carcinoma: a review.J R Soc Med. 1980 Sep;73(9):659-63. doi: 10.1177/014107688007300913. J R Soc Med. 1980. PMID: 7017135 Free PMC article. Review. No abstract available.